Samsung BioLogics to establish US footprint with development labs
Korean CDMO Samsung BioLogics will open labs in either the Boston or San Francisco area early 2020 on the back of demand for its development services. In 2017, Samsung BioLogics added the ‘D’ to its contract development and manufacturing organization (CDMO) credentials by announcing plans to ...
Amgen says biosimilars represent an opportunity to get to market without the risk or cost of a novel biologic, so long as you have the capabiliti ...
With Brammer and Paragon contracts, Sarepta Therapeutics has ample gene therapy manufacturing capacity but says it is now working on analytical a ...
Pfizer will relocate clinical manufacturing activities from its Chapel Hill site to a newly acquired facility nearby in the latest ramp up of its ...
New GMP and licensing laws will reshape biopharma contracting in China. But exactly what the sector will look like will depend on how they are im ...
Recent Tweets
-
RT @Dan5tanton: @pfizer adds $19m plant in NC clinical #genetherapy shake-up: Plans to relocate ops from nearby former-Bamboo Chape… https://t.co/v6wMzvp0tp
2 days ago
-
RT @Dan5tanton: Missed the @Xconomy #Xconxcelerate startup pitch comp at #BiotechWeekBoston last week? Well @BioProInsider was in t… https://t.co/rFQg2ycvAa
4 days ago
-
RT @BioProInsider: #CDMO AGC Biologics to exit Berkeley CA plant by end of year. Site, bought from XOMA in 2012, no longer fits with g… https://t.co/jDifhLYTbB
6 days ago
-
#CDMO AGC Biologics to exit Berkeley CA plant by end of year. Site, bought from XOMA in 2012, no longer fits with g… https://t.co/jDifhLYTbB
6 days ago
Trending
2019
Gyrolab Immunoassays: Streamlining Workflows Through Automation
Ask the Experts
Automated, Closed-Loop, Inline Monitoring of CAR-T Cells in a Production Process
BPI White Papers
Streamlining the Antibody Discovery Workflow at ModiQuest Research
Analytical
Embedded Particles in Single-Use Bags: Risk to Bag Integrity and Drug Product Purity, or Only a Cosmetic Defect?